Boston Scientific Corporation develops ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac ...
Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can ... worsening heart failure in people with CIEDs – pacemakers, implantable cardioverter defibrillators ...
The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.
Abbott Laboratories ABT is set to report fourth-quarter fiscal 2024 results on Jan. 22. See the Zacks Earnings Calendar to ...
“The way I think of a spinal cord stimulator is sort of like a pacemaker for pain,” said Dr. Erika Petersen ... Abbott’s Proclaim XR SCS system and Boston Scientific’s WaveWriter Alpha SCS system have ...
Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback